Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2013 - New Market Report
Global Markets Direct's, 'Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uterine Leiomyoma (Uterine Fibroids). Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release